| Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection TH Price, M Boeckh, RW Harrison, J McCullough, PM Ness, RG Strauss, ... Blood, The Journal of the American Society of Hematology 126 (18), 2153-2161, 2015 | 227 | 2015 |
| Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial L Uhl, SF Assmann, TH Hamza, RW Harrison, T Gernsheimer, SJ Slichter Blood, The Journal of the American Society of Hematology 130 (10), 1247-1258, 2017 | 121 | 2017 |
| Drug survival of ixekizumab, TNF inhibitors, and other IL‐17 inhibitors in real‐world patients with psoriasis: the Corrona psoriasis registry B Lockshin, A Cronin, RW Harrison, RR McLean, L Anatale‐Tardiff, ... Dermatologic Therapy 34 (2), e14808, 2021 | 36 | 2021 |
| Characterization of patients with psoriasis in challenging-to-treat body areas in the Corrona Psoriasis Registry K Callis Duffin, MA Mason, K Gordon, RW Harrison, MM Crabtree, ... Dermatology 237 (1), 46-55, 2021 | 29 | 2021 |
| Prospective cohort study of psoriatic arthritis risk in patients with psoriasis in a real-world psoriasis registry A Ogdie, RW Harrison, RR McLean, T Lin, M Lebwohl, BE Strober, J Zhuo, ... Journal of the American Academy of Dermatology 87 (6), 1303-1311, 2022 | 18 | 2022 |
| An open‐label, phase 2, single centre, randomized, crossover design bioequivalence study of AndroForte 5 testosterone cream and Testogel 1% testosterone gel in hypogonadal men … GA Wittert, RW Harrison, MJ Buckley, J Wlodarczyk Andrology 4 (1), 41-45, 2016 | 15 | 2016 |
| WBC alloimmunization: effects on the laboratory and clinical endpoints of therapeutic granulocyte transfusions TH Price, J McCullough, RG Strauss, PM Ness, TH Hamza, RW Harrison, ... Transfusion 58 (5), 1280-1288, 2018 | 14 | 2018 |
| No obesity paradox in pediatric patients with dilated cardiomyopathy CD Castleberry, JL Jefferies, L Shi, JD Wilkinson, JA Towbin, ... JACC: Heart Failure 6 (3), 222-230, 2018 | 14 | 2018 |
| Psoriasis severity, comorbidities, and treatment response differ among geographic regions in the United States CW Enos, KA O’Connell, RW Harrison, RR McLean, B Dube, ... JID Innovations 1 (2), 100025, 2021 | 12 | 2021 |
| Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a … PJ Mease, NA Accortt, S Rebello, CJ Etzel, RW Harrison, GA Aras, ... Rheumatology international 39 (9), 1547-1558, 2019 | 7 | 2019 |
| A randomized controlled trial on the efficacy of high-dose granulocyte transfusion therapy in neutropenic patients with infection TH Price, J McCullough, P Ness, RG Strauss, SM Pulkrabek, R Harrison, ... Blood 124 (21), 597, 2014 | 7 | 2014 |
| Outcomes in ixekizumab patients following exposure to secukinumab and other biologics in the CorEvitas psoriasis registry B Lockshin, RW Harrison, RR McLean, MM Crabtree, BW Konicek, B Zhu, ... Dermatology and Therapy 12 (12), 2797-2815, 2022 | 6 | 2022 |
| Disease response and patient-reported outcomes among initiators of ixekizumab M Shahriari, RW Harrison, R Burge, CY Lin, WN Malatestinic, ... Journal of Dermatological Treatment 33 (3), 1538-1546, 2022 | 6 | 2022 |
| Describing the clinical and patient-reported outcomes of patients with scalp psoriasis enrolled in the Corrona Psoriasis Registry K Callis-Duffin, C Karki, MA Mason, K Gordon, RW Harrison, A Guana, ... JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 79 (3), AB105-AB105, 2018 | 5 | 2018 |
| Impact of PCA strategies on pain intensity and functional assessment measures in adults with sickle cell disease during hospitalized vaso-occlusive episodes CD Dampier, CG Wager, R Harrison, LL Hsu, CP Minniti, WR Smith, ... American journal of hematology 87 (10), E71, 2012 | 5 | 2012 |
| Geographic Variations in Biologic Therapy and Disease Characteristics: A Pilot-Study in the Corrona Psoriasis Registry. CW Enos, KA O'Connell, RW Harrison, RR McLean, B Dude, ... Journal of Drugs in Dermatology: JDD 19 (11), 1119-1122, 2020 | 4 | 2020 |
| The burden of nail psoriasis: a real-world analysis from the Corrona Psoriasis Registry K Callis-Duffin, C Karki, MA Mason, K Gordon, RW Harrison, A Guana, ... JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 79 (3), AB283-AB283, 2018 | 4 | 2018 |
| Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry C Yu, G Wang, RT Burge, E Ye, G Dou, J Li, RW Harrison, RR McLean, ... Dermatology and Therapy 13 (1), 187-206, 2023 | 2 | 2023 |
| Poor patient-reported outcomes and impaired work productivity in patients with inflammatory bowel disease in remission RK Cross, JS Sauk, J Zhuo, RW Harrison, SJ Kerti, K Emeanuru, J O’Brien, ... Gastro Hep Advances 1 (6), 927-935, 2022 | 2 | 2022 |
| Understanding characteristics of patients newly initiating ixekizumab: findings from the Corrona Psoriasis Registry JJ Wu, RW Harrison, B Zhu, OM Goldblum, WN Malatestinic, R Burge, ... Journal of Comparative Effectiveness Research 10 (2), 157-167, 2021 | 2 | 2021 |
